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Salmonella enterica serovar Typhimurium avoids
clearance by the host immune system by sup-
pressing T cell responses; however, the mechanisms
that mediate this immunosuppression remain
unknown. We show that S. Typhimurium inhibit
T cell responses by producing L-Asparaginase II,
which catalyzes the hydrolysis of L-asparagine to
aspartic acid and ammonia. L-Asparaginase II is
necessary and sufficient to suppress T cell blasto-
genesis, cytokine production, and proliferation and
to downmodulate expression of the T cell receptor.
Furthermore, S. Typhimurium-induced inhibition
of T cells in vitro is prevented upon addition of
L-asparagine. S. Typhimurium lacking the L-Aspara-
ginase II gene (STM3106) are unable to inhibit T cell
responses and exhibit attenuated virulence in vivo.
L-Asparaginases are used to treat acute lympho-
blastic leukemia through mechanisms that likely
involve amino acid starvation of leukemic cells,
and these findings indicate that pathogens sim-
ilarly use L-asparagine deprivation to limit T cell
responses.
INTRODUCTION
Salmonellae are a leading cause of worldwide morbidity and
mortality in humans (Pegues et al., 2005). Infections with
Salmonellae range in severity from self-limiting gastroenter-
itis to typhoid fever. Nontyphoidal Salmonellae such as
S. Typhimurium are a leading cause of inflammatory enteroco-
litis and death due to foodborne illness. Typhoidal Salmonellae
such as S. Typhi cause systemic infections characterized byCell Host &bacterial penetration of the intestinal barrier and extraintestinal
dissemination to the liver and spleen, where the microorganisms
replicate in professional phagocytes. Septic shock and death
can occur if the infection is left untreated. S. Typhimurium cause
a typhoid-like systemic illness in susceptible strains of mice, and
experimental infection of mice with S. Typhimurium has served
as a useful model for the human disease caused by S. Typhi
(Tsolis et al., 2011).
Many bacterial pathogens induce acute immunosuppression
to establish infection. A number of bacterial pathogens subvert
pathways of the innate immune system, but how bacterial
pathogens overcome pathways of the adaptive immune system
is not well understood (Hornef et al., 2002). Recent studies
demonstrating that S. Typhimurium, Shigella flexneri, Yersinia
spp., and Helicobacter pylori directly inhibit the response of
T cells provided insight into the types of strategies used by
bacterial pathogens to overcome pathways of the adaptive
immune system (Algood and Cover, 2006; Fischer et al., 2009;
Konradt et al., 2011; van der Velden et al., 2005, 2008;
Viboud and Bliska, 2005). In humans and animal models,
S. Typhimurium induce acute immunosuppression and delay
the onset of a protective immune response (Dougan et al.,
2011; Luu et al., 2006; Srinivasan et al., 2004; Tsolis
et al., 2011). Immunity that eventually develops against
S. Typhimurium requires humoral and cell-mediated immune
responses (Dougan et al., 2011). T cells play a critical role in
clearance of S. Typhimurium (Dougan et al., 2011), but the
T cell response to these microorganisms is thwarted during
infection (Bueno et al., 2007; Ertelt et al., 2011; Johanns et al.,
2010; Sad et al., 2008; Srinivasan and McSorley, 2007).
We previously demonstrated that T cells fail to proliferate in
response to antigen-pulsed dendritic cells when S. Typhimurium
are present (van der Velden et al., 2005). Although
S. Typhimurium can kill dendritic cells by a mechanism that
depends on host caspase-1 and the Salmonella pathogenicity
island 1 (SPI-1)-encoded type 3 secretion system (van der
Velden et al., 2003), the killing of dendritic cells alone is notMicrobe 12, 791–798, December 13, 2012 ª2012 Elsevier Inc. 791
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Figure 1. Only Viable S. Typhimurium and
ThoseCapableofSynthesizingNewProteins
Are Able to Downmodulate TCR Expression
and Suppress T Cell Blastogenesis
(A and B) Expression of surface TCR-b by CD25+
T cells left uninfected (UI, gray in histograms) or
cultured with viable S. Typhimurium (STm) or
formaldehyde-fixed S. Typhimurium (Fixed STm);
p = 0.0002.
(C and D) Blastogenesis of CD25+ T cells treated
as in (A); p = 0.0054.
(E and F) Expression of surface TCR-b by CD25+
T cells left uninfected (UI, gray in histograms)
or cultured with untreated S. Typhimurium (STm)
or chloramphenicol-treated S. Typhimurium (Cm-
treated STm); p < 0.0001.
(G and H) Blastogenesis of CD25+ T cells treated
as in (E); p = 0.0004. Data are representative of (A),
(C), (E), and (G), or show the mean with SEM
(B, D, F, and H) from at least three independent
experiments.
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Salmonella L-Asparaginase II Inhibits T Cellsresponsible for the lack of T cell proliferation (van der Velden
et al., 2005). When T cells are stimulated in the absence of
dendritic cells through ligation of the T cell receptor (TCR)
complex, the robust proliferation of T cells that usually occurs
fails to occur when S. Typhimurium are present (van der Velden
et al., 2005). A proteinaceous factor present in medium
harvested from T cells cultured with S. Typhimurium is respon-
sible for this inhibition (van der Velden et al., 2005, 2008), but
the identity of the factor, which may be produced or induced
by S. Typhimurium, has remained elusive.
Here, we demonstrate that S. Typhimurium utilizes L-Aspara-
ginase II to inhibit the response of T cells and that production of
L-Asparaginase II by S. Typhimurium is both necessary and
sufficient to cause inhibition of T cells. The identification of the
factor responsible for S. Typhimurium-induced T cell inhibition
provides an understanding of a mechanism by which these
microorganisms can establish infection in the mammalian host
and avoid clearance by the immune system.792 Cell Host & Microbe 12, 791–798, December 13, 2012 ª2012 Elsevier Inc.RESULTS
Only Viable S. Typhimurium and
ThoseCapable of Synthesizing New
Proteins Are Able to Downmodulate
TCR Expression and Suppress
T Cell Blastogenesis
S. Typhimurium-induced inhibition of
T cell proliferation correlates with down-
modulation of TCR-b, a receptor required
for antigen recognition and T cell function
(van der Velden et al., 2005, 2008). To
determine whether downmodulation of
TCR-b by S. Typhimurium requires
viable microorganisms, we cultured
T cells with live or formaldehyde-fixed
S. Typhimurium. After 20 hr of incuba-
tion, T cells cultured with viable
S. Typhimurium expressed significantlyless surface TCR-b than T cells left uninfected (Figures 1A
and 1B). In contrast, T cells cultured with formaldehyde-fixed
S. Typhimurium expressed levels of surface TCR-b that were
comparable to the levels expressed by T cells left uninfected
(Figures 1A and 1B). Additionally, blastogenesis of T cells
cultured with viable S. Typhimurium was significantly reduced
compared with that of T cells left uninfected or cultured with
formaldehyde-fixed S. Typhimurium (Figures 1C and 1D).
To determine whether new protein synthesis by
S. Typhimurium is required for downmodulation of TCR-b,
we added chloramphenicol to T cells cultured with chloram-
phenicol-pretreated bacteria. After 20 hr of incubation, T cells
cultured with chloramphenicol-treated S. Typhimurium ex-
pressed levels of surface TCR-b that were comparable to the
levels expressed by T cells left uninfected (Figures 1E
and 1F). Additionally, blastogenesis of T cells cultured with
S. Typhimurium was significantly increased when chloram-
phenicol was present (Figures 1G and 1H). Thus, S. Typhimurium
Cell Host & Microbe
Salmonella L-Asparaginase II Inhibits T Cellsmust be viable and able to synthesize new proteins to downmo-
dulate TCR-b expression and suppress T cell blastogenesis.
STM3106 Is Required for S. Typhimurium to
Downmodulate TCR Expression, Suppress T Cell
Blastogenesis, Block Cytokine Production, and Inhibit
T Cell Proliferation
To identify the S. Typhimurium genes required for inhibition of
T cells, we screened a library of 156 mutants. Each mutant in
this library carries a targeted deletion of multiple linked, nones-
sential genes (1,700 genes are deleted in the library). The
mutants were screened individually to identify those that were
unable to downmodulate TCR-b surface expression. One
mutant, DSTM3104-7, was unable to downmodulate TCR-b
(Figures 2A and 2B). To identify the gene(s) deleted in this mutant
required for S. Typhimurium to downmodulate TCR-b, we gener-
ated strains with targeted deletions of STM3104, STM3105,
STM3106, or STM3107. Only DSTM3106 S. Typhimurium were
unable to downmodulate TCR-b (Figure 2C). The presence of
STM3106 in trans complemented the phenotype of DSTM3106
S. Typhimurium (Figures 2D, 2E, and S1A–S1F available online).
Consistent with these results, S. Typhimurium lacking STM3106
also were unable to suppress T cell blastogenesis (Figures 2F
and 2G) and inhibit production of interferon (IFN)-g (Figures
2H, 2I, S1G, and S1H) and interleukin (IL)-2 (Figures 2J, 2K,
S1I, and S1J). S. Typhimurium did not efficiently invade T cells
(Figures S1K and S1L), and S. Typhimurium lacking STM3106
grew normally in bacterial culture medium (Figure S1M) and
bone-marrow-derived macrophages (Figure S1N), indicating
that DSTM3106 S. Typhimurium do not have a generalized
growth defect.
To determine whether STM3106 is required for
S. Typhimurium to inhibit T cell proliferation, we labeled T cells
with carboxyfluorescein succinimidyl ester (CFSE) and cultured
them with wild-type (WT) or DSTM3106 S. Typhimurium.
After 3 days of incubation, T cells cultured with WT
S. Typhimurium had not proliferated in response to stimulus
(Figures 2L and 2M). In contrast, T cells cultured with
DSTM3106 S. Typhimurium, like the T cells that were left unin-
fected, had proliferated extensively (Figures 2L and 2M). Collec-
tively, these results demonstrate that STM3106 is required for
S. Typhimurium to downmodulate TCR-b expression, suppress
T cell blastogenesis, block cytokine production, and inhibit
T cell proliferation.
L-Asparaginase II Encoded by STM3106 Is Necessary
and Sufficient to Cause Inhibition of T Cells
STM3106 (ansB) encodes L-Asparaginase II, an extracyto-
plasmic enzyme that catalyzes the hydrolysis of L-asparagine
to L-aspartic acid and ammonia (Figure 3A). We previously
showed that a proteinaceous factor capable of downmodulating
TCR-b was present in medium harvested from T cells cultured
with S. Typhimurium (van der Velden et al., 2008). To determine
whether this inhibitory factor could be L-Asparaginase II
produced by S. Typhimurium, we subjected medium harvested
from T cells cultured with S. Typhimurium to western blot anal-
ysis. The presence of L-Asparaginase II in medium could not
be detected (Figure S2A), but the capacity of the medium to
downmodulate TCR-b was lost when L-Asparaginase II-specificCell Host &antibody was used in immunodepletion experiments (Figure 3B).
In contrast, the capacity of the medium to downmodulate TCR-b
was retained when control antibody or no antibody was
used (Figure 3B). Thus, L-Asparaginase II is necessary for
S. Typhimurium to cause downmodulation of TCR-b.
To determine whether L-Asparaginase II of S. Typhimurium is
sufficient to cause downmodulation of TCR-b, we treated T cells
with purified L-Asparaginase II. After 20 hr of incubation, T cells
treated with purified L-Asparaginase II expressed significantly
less surface TCR-b than did T cells left untreated (Figures 3C
and S2A–S2C). Furthermore, T cells treated with purified
L-Asparaginase II expressed levels of surface TCR-b that were
comparable to the levels expressed by T cells cultured with
WT S. Typhimurium (Figures 3C, S2B, and S2C). T cells treated
with purified L-Asparaginase II also expressed significantly less
intracellular IFN-g and IL-2 than did T cells left untreated (Figures
S2D and S2E). Thus, L-Asparaginase II of S. Typhimurium
is sufficient to cause inhibition of T cells.
To determine whether depletion of L-Asparaginase II
substrate is responsible for S. Typhimurium-induced inhibition
of T cells, we added L-asparagine to T cells cultured with
S. Typhimurium. Exogenous L-asparagine, but not L-aspartate
or L-glutamine, prevented S. Typhimurium-induced downmodu-
lation of TCR-b (Figure 3D). These results suggest that L-Aspar-
aginase II-mediated depletion of L-asparagine contributes to
S. Typhimurium-induced downmodulation of TCR-b.
An S. Typhimurium ansB Mutant Unable to Express
L-Asparaginase II Is Attenuated for Virulence
To determine whether STM3106 (ansB) is required for virulence
of S. Typhimurium, we performed survival assays using
129X1/SvJ mice, which have served as a useful model for
studying persistent salmonellosis. Significantly more mice
survived infection with DSTM3106 S. Typhimurium than with
WT S. Typhimurium (Figure 4A). A similar trend was observed
for C57BL/6J mice, which are more susceptible to infection
with S. Typhimurium (Figures S3A and S3B). Organ burden
assays were performed on the surviving mice to determine
bacterial loads. After 60 days of infection, a long-term time point
used to assess bacterial persistence (Johanns et al., 2010;
Lawley et al., 2006; Mittru¨cker et al., 2002), significantly fewer
DSTM3106 S. Typhimurium than WT S. Typhimurium were
recovered from livers, but not spleens and mesenteric lymph
nodes (Figure 4B). Additional organ burden assays were
performed to determine the kinetics of WT and DSTM3106
S. Typhimurium infection. Similar numbers of WT and
DSTM3106 S. Typhimurium were recovered from spleens and
livers during early stages of infection (Figures 4C and 4D). In
contrast, significantly fewer DSTM3106 S. Typhimurium than
WT S. Typhimurium were recovered from livers, but not spleens,
during later stages of infection (Figures 4C and 4D). The pres-
ence of STM3106 in trans complemented the colonization defect
of DSTM3106 S. Typhimurium in liver (Figures 4E and S3C).
Multiparametric flow cytometry was used to determine whether
S. Typhimurium utilize L-Asparaginase II to inhibit the response
of T cells in vivo. More T cells, including activated T cells and
IFN-g-producing T cells, were recovered from the livers and
spleens of mice infected with DSTM3106 S. Typhimurium
than from the livers and spleens of mice infected with WTMicrobe 12, 791–798, December 13, 2012 ª2012 Elsevier Inc. 793
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Salmonella L-Asparaginase II Inhibits T CellsS. Typhimurium (Figures S3D–S3I). However, these differences
did not reach statistical significance. Collectively, these
results demonstrate that STM3106 (ansB), and therefore
L-Asparaginase II, is required for virulence of S. Typhimurium
in mouse models of infection, and that S. Typhimurium utilize
L-Asparaginase II to colonize and persist in the liver. Further-
more, these results suggest that the attenuation in virulence
of DSTM3106 S. Typhimurium may be due to a reduced ability
of these bacteria to inhibit the response of T cells in vivo.
DISCUSSION
We report that S. Typhimurium utilize L-Asparaginase II to inhibit
the response of T cells, and that production of L-Asparaginase II
by S. Typhimurium is both necessary and sufficient to cause
inhibition of T cells. Our identification of the factor responsible
for S. Typhimurium-induced T cell inhibition provides an under-
standing of a previously unrecognized mechanism by which
these microorganisms can establish infection in the mammalian
host and avoid clearance by the immune system. An immediate
implication of our results is that production of L-Asparaginase II
by S. Typhimurium causes depletion of exogenous
L-asparagine, leading to downmodulation of TCR-b expression,
suppression of T cell blastogenesis, blockade of cytokine
production, and, ultimately, inhibition of T cell proliferation.
Consistent with a role for L-Asparaginase II in S. Typhimurium-
induced T cell immunosuppression, which was previously
shown to also involve S. Typhimurium genes encoded by the
virulence plasmid (Hoertt et al., 1989) and SPI-2 (Ertelt et al.,
2011), in vivo phenotypes revealed themselves during later
stages of infection, when the adaptive immune system is fully
engaged. Another important and more general implication of
our work is that a metabolic enzyme can function beyond its
canonical role in catalyzing the hydrolysis of L-asparagine to
aspartic acid and ammonia.
L-asparaginases are used clinically to treat acute lympho-
blastic leukemia (ALL) by a mechanism that is thought to involve
depletion of exogenous L-asparagine and, to a lesser extent,
L-glutamine (Avramis and Tiwari, 2006; Pieters et al., 2011). In
a significant number of patients with ALL, malignant cells exhibit
a metabolic defect in L-asparagine synthesis and are dependent
on an exogenous source of L-asparagine for survival (Avramis
and Tiwari, 2006). Normal cells are able to synthesize L-aspara-
gine and thus are less affected by the rapid depletion of this
important amino acid following treatment with L-asparaginase
(Avramis and Tiwari, 2006).Figure 2. STM3106 Is Required for S. Typhimurium to Downmodulat
Production, and Inhibit T Cell Proliferation
(A) Expression of surface TCR-b by CD25+ T cells left uninfected (UI) or cultured
(B) Genetic organization of the chromosomal region deleted in DSTM3104-7 S. T
(C) Expression of surface TCR-b by CD25+ T cells left UI or cultured with WT, DS
(D and E) Expression of surface TCR-b by CD25+ T cells left UI (gray in histograms
S. Typhimurium carrying plasmid pBAD18-Cm (DSTM3106/pBAD), or DSTM31
(DSTM3106/pBAD-STM3106); p < 0.0001.
(F and G) Blastogenesis of CD25+ T cells treated as in (D); p < 0.0001.
(H and I) Expression of intracellular IFN-g by CD25+ T cells treated as in (D); p <
(J and K) Expression of intracellular IL-2 by CD25+ T cells treated as in (D); p = 0
(L andM) Proliferation of CFSE-labeled T cells left UI or cultured withWT orDSTM
(L), or show the mean with SEM (A, C, E, G, I, K, and M) from at least three indep
Cell Host &T cells are extremely sensitive to amino acid deprivation
(Powell and Delgoffe, 2010) and, like malignant cells in ALL,
may be dependent on an exogenous source of L-asparagine
when undergoing themetabolically demanding process of clonal
expansion. Thus, the mechanism by which S. Typhimurium uses
L-Asparaginase II to inhibit the response of T cells may be similar
to the mechanism by which clinically administered L-asparagi-
nases help eliminate human cancers. The mechanistic details
of how inhibition occurs are supported by recent studies demon-
strating that purified L-Asparaginase II from S. enteritidis and
H. pylori can inhibit protein synthesis, block cell-cycle progres-
sion, and suppress replication of cultured cell lines (Iwamaru
et al., 2001; Scotti et al., 2010; Shibayama et al., 2011). Addi-
tional support comes from our own work indicating that
S. Typhimurium expressing catalytic-site mutants of L-Asparagi-
nase II are unable to inhibit the response of T cells (A.T. and
A.W.M.v.d.V., unpublished data).
Although the canonical function of L-Asparaginase II is to
catalyze the hydrolysis of L-asparagine to aspartic acid and
ammonia, it is striking to consider the possibility that an enzyme
that is used clinically to suppress T cell cancers also serves as
a virulence determinant that allows S. Typhimurium to suppress
T cells directed against it. Our work establishes that L-Asparagi-
nase II has important functions in infection and immunity, leaving
open the possibility that S. Typhimurium produces and secretes
L-Asparaginase II to consume L-asparagine and thus compete
with the host for nutrients. The L-Asparaginase II gene ansB is
highly conserved in Gram-negative bacteria and has been
shown to contribute to the virulence of several important human
pathogens, including S. Typhimurium (this study), H. pylori
(Shibayama et al., 2011), and Campylobacter jejuni, which also
use L-Asparaginase II to colonize and persist in the liver
(Hofreuter et al., 2008). Thus, L-Asparaginase II could prove to
be a promising target for the development of innovative, broad-
spectrum therapeutic approaches and preventive measures to
overcome bacterial infections.EXPERIMENTAL PROCEDURES
Bacterial Strains, Strain Construction, and Culture Conditions
S. Typhimurium strain 14028 (American Type Culture Collection) and the
isogenic, spontaneous, nalidixic acid-resistant derivative S. Typhimurium
strain IR715 (Stojiljkovic et al., 1995) were used as WT strains. S. Typhimurium
were grown aerobically at 37C in Luria-Bertani (LB) broth or on LB agar. WT
S. Typhimurium, but not DSTM3106 S. Typhimurium, expressed L-Asparagi-
nase II under these conditions (Figure S2F). Where noted, S. Typhimurium
were fixed with Fixation Buffer (BioLegend) for 30 min or treated withe TCR Expression, Suppress T Cell Blastogenesis, Block Cytokine
with either WT or DSTM3104-7 S. Typhimurium; p < 0.0001.
yphimurium.
TM3104, DSTM3105, DSTM3106, or DSTM3107 S. Typhimurium; p < 0.0001.
) or cultured with WT S. Typhimurium, DSTM3106 S. Typhimurium,DSTM3106
06 S. Typhimurium carrying a derivative of pBAD18-Cm encoding STM3106
0.0001.
.0001.
3106 S. Typhimurium; p = 0.0021. Data are representative of (D), (F), (H), (J), and
endent experiments. See also Figure S1.
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Figure 3. L-Asparaginase II Encoded by STM3106 Is Necessary and
Sufficient to Cause Downmodulation of the TCR
(A) STM3106 encodes L-Asparaginase II, an extracytoplasmic enzyme that
catalyzes the hydrolysis of L-asparagine to L-aspartic acid and ammonia.
(B) Expression of surface TCR-b by CD25+ T cells incubated with filtered
medium harvested from T cells left uninfected (UI) or infected with WT
S. Typhimurium (STm). This medium had been subjected to immunodepletion
using L-Asparaginase II-specific antibody (a-L-Asparaginase II Ab), control
antibody (Control Ab), or no antibody (No Ab); p < 0.0001.
(C) Expression of surface TCR-b by CD25+ T cells left UI, cultured with STm, or
treated with purified L-Asparaginase II; p = 0.0018.
(D) Expression of surface TCR-b by untreated, L-asparagine-treated (L-Asn),
L-aspartate-treated (L-Asp), or L-glutamine-treated (L-Gln) CD25+ T cells left
UI or cultured with STm; p < 0.0001. Data show the mean with SEM from at
least three independent experiments. See also Figure S2.
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Salmonella L-Asparaginase II Inhibits T Cellschloramphenicol (100 mg/ml) for 2 hr. To generate bacterial growth curves,
S. Typhimurium were grown aerobically at 37C in LB broth for 18 hr. The
resulting overnight cultures were diluted 1:100 in LB broth and grown aerobi-
cally at 37C to stationary phase (7 hr). The optical density at 600 nm
(OD600nm) was measured every 30 min.
Targeted, kanamycin-resistant multi- and single-gene deletion mutants
were constructed using the lambda red recombinase method (Datsenko and796 Cell Host & Microbe 12, 791–798, December 13, 2012 ª2012 ElsWanner, 2000) as described previously (Santiviago et al., 2009). Multi-gene
deletion mutants were designed to avoid genes known to be essential for
growth on rich medium (M.M. and H.A.-P., unpublished data). Each mutation
removed a variable number of genes depending on the nature of the
surrounding genes. For mouse infection experiments, mutations were moved
from S. Typhimurium strain 14028 into S. Typhimurium strain IR715 by P22-
mediated transduction.
Mouse Experiments
Survival assays and organ burden assays were performed using 8- to 10-
week-old C57BL/6J and 129X1/SvJ mice (The Jackson Laboratory). These
strains of mice have been used as model hosts to study acute and persistent
infections with Salmonellae, respectively (Tsolis et al., 2011). Mice were inoc-
ulated intragastrically with either WT S. Typhimurium strain IR715 or isogenic,
DSTM3106 S. Typhimurium (5 3 105 colony forming units [cfu] for C57BL/6J
mice and 5 3 107 cfu for 129X1/SvJ mice) suspended in 0.1 ml of PBS. F1
(C57BL/6J 3 129X1/SvJ) hybrid mice were used to determine whether the
presence of STM3106 in trans complemented the colonization defect of
DSTM3106 S. Typhimurium in liver, because 129X1/SvJ mice were not
commercially available in a timely fashion. To minimize concerns about
plasmid loss over time, mice were inoculated intravenously with 5 3 103 cfu
of WT S. Typhimurium strain IR715, isogenic DSTM3106 S. Typhimurium, or
isogenic DSTM3106 S. Typhimurium carrying plasmid pWSK29-STM3106,
and bacterial loads per liver were determined after 10 days of infection. Ten-
fold serial dilutions of the inoculum were plated on LB agar to determine the
inoculum titer. The mice were monitored for survival and were euthanized
when they became moribund, or at the termination of the experiment
(30 days and 60 days after infection for C57BL/6J mice and 129X1/SvJ
mice, respectively). At various times after infection, target organs were
harvested from 129X1/SvJ or F1 (C57BL/6J 3 129X1/SvJ) hybrid mice and
the bacterial burden per gram of tissue was quantified by plating for cfu on
LB agar containing nalidixic acid (50 mg/ml), kanamycin (60 mg/ml), or
carbenicillin (100 mg/ml). The Institutional Animal Care and Use Committee
at Stony Brook University approved all of the animal studies.
T Cell Enrichment and T Cell Assays
Splenocytes harvested from C57BL/6J mice were used as a source of T cells.
Following treatment of splenocytes with ACK lysing buffer (Invitrogen) to lyse
red blood cells, CD90.2-conjugated MACS microbeads and magnetic
separation columns (Miltenyi Biotec) were used for the enrichment of T cells.
Enriched populations of T cells were suspended in RP-10 (i.e., RPMI 1640
medium; Invitrogen) supplemented with 10% fetal bovine serum (Atlanta
Biologicals), L-Gln, HEPES, and 50 mM 2-ME) and used in T cells assays.
S. Typhimurium-induced or L-Asparaginase II-induced downmodulation
of TCR-b, suppression of T cell blastogenesis, and inhibition of cytokine
production was measured by flow cytometry. Briefly, T cells were seeded
at 1 3 105 cells per well (96-well format) in tissue culture plates coated
with 5 mg/ml of anti-CD3ε (clone 145-2C11; BioLegend). T cells were cultured
in the absence or presence of bacteria at a multiplicity of infection of 50 or
purified L-Asparaginase II. After 2 hr of incubation at 37C/5% CO2, T cells
were pelleted by centrifugation and resuspended in medium supplemented
with penicillin/streptomycin (2%) and gentamicin (50 mg/ml), killing all
bacteria within 2 hr (data not shown). After an additional 18–20 hr of in-
cubation at 37C/5% CO2, T cells were harvested, stained, and analyzed
by flow cytometry. T cells treated with conditioned medium or purified
L-Asparaginase II were incubated for 18–20 hr in the presence of antibiotics,
as described above. Where noted, medium was supplemented with
chloramphenicol (100 mg/ml), L-asparagine (10 mM), L-aspartate (10 mM),
or L-glutamine (10 mM).
S. Typhimurium-induced inhibition of T cell proliferation was measured by
flow cytometry. Briefly, T cells enriched from mouse spleens were labeled
with 5 mM CFSE (Invitrogen) and seeded at 1 3 105 cells per well (96-well
format) in tissue culture plates coated with 5 mg/ml of anti-CD3ε. CFSE is
distributed evenly among daughter cells with each round of cell division,
resulting in a measurable reduction in cell fluorescence (Parish et al.,
2009). T cells were left untreated or infected with bacteria at a multiplicity of
infection of 50. After 2 hr of incubation at 37C/5% CO2, T cells were
pelleted by centrifugation and resuspended in medium supplemented withevier Inc.
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Figure 4. An S. Typhimurium ansB Mutant Unable to Express L-Asparaginase II Is Attenuated for Virulence in Mouse Models of Infection
(A) Survival of 129X1/SvJmice (n = 15 per group) inoculated intragastrically with 53 107 cfu ofWT (squares) orDSTM3106 (triangles) S. Typhimurium; p = 0.0183.
(B) Bacterial loads per gram of tissue harvested from 129X1/SvJ mice (n = 15 per group) 60 days after intragastric inoculation with 53 107 cfu of WT (squares) or
DSTM3106 (triangles) S. Typhimurium; p = 0.0003 for liver. At the time of harvest, eight mice infected with WT S. Typhimurium and four mice infected with
DSTM3106 S. Typhimurium had succumbed.
(C and D) Bacterial loads per gram of liver (C) and spleen (D) tissue harvested from 129X1/SvJ mice (n = 5 per group per time point) at various times after
intragastric inoculation with 5 3 107 cfu of WT (squares) or DSTM3106 (triangles) S. Typhimurium; p = 0.0001 for liver and p = 0.2905 for spleen.
(E) Bacterial loads per gram of liver tissue harvested from F1 (C57BL/6J 3 129X1/SvJ) hybrid mice (n = 8 per group) 10 days after intravenous inoculation with
53 103 cfu of WT S. Typhimurium,DSTM3106 S. Typhimurium, orDSTM3106 S. Typhimurium carrying a derivative of pWSK29 encoding STM3106 (DSTM3106/
pWSK29-STM3106); p = 0.0111. Data show the mean with SEM. See also Figure S3.
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Salmonella L-Asparaginase II Inhibits T Cellspenicillin/streptomycin (2%) and gentamicin (50 mg/ml). After an additional
3 days of incubation at 37C/5% CO2, T cells were harvested, stained, and
analyzed by flow cytometry.
Immunodepletion
Conditionedmedium (1.75ml) from T cells cultured in the absence or presence
of S. Typhimurium was passed through a 0.22 mm filter. The resulting samples
were aliquoted into 250 ml fractions that were precleared using 25 ml of protein
A-coupled sepharose beads (Sigma), with agitation. After 1 hr of incubation at
4C, the beads were pelleted by centrifugation and the supernatants were
collected. Where noted, 22.5 mg of polyclonal rabbit anti-Escherichia coli
L-Asparaginase II antibody or rabbit anti-mouse IgG control antibody (both
Abcam) was added to the precleared supernatants. L-Asparaginase II of
E. coli is 96% identical to L-Asparaginase II of S. Typhimurium at the amino
acid level, and T cells treated with purified L-Asparaginase II of E. coli (Sigma),
like T cells treated with purified L-Asparaginase II of S. Typhimurium, ex-
pressed levels of surface TCR-b comparable to the levels expressed by
T cells cultured with WT S. Typhimurium (Figure S2G). After overnight incuba-
tion at 4C with rotation, 25 ml of protein A-coupled sepharose beads were
added to each sample. After an additional 3 hr of incubation at 4C withCell Host &agitation, the beads were pelleted by centrifugation and the resulting superna-
tants were used in T cell assays.
Statistical Analysis
Statistical analysis of survival assays and organ burden assays was
performed using the log-rank test and one-tailed, nonparametric Mann-
Whitney test or two-way ANOVA, respectively. Statistical analysis of all
other assays was performed using a two-tailed paired t test (invasion
assay) or repeated-measures (randomized-block) one-way ANOVA with
Bonferroni’s multiple-comparison post test, comparing selected pairs of
columns. Statistical analysis was performed using Prism 5.0b (GraphPad
Software), and p values < 0.05 were considered to be statistically significant.
Asterisks indicate statistically significant differences (***p < 0.001, **p < 0.01,
*p < 0.05).
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